The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
Antibody-mediated immunity plays a key role in protection against SARS-CoV-2. We characterized B-cell-derived anti-SARS-CoV-2 RBD antibody repertoires from vaccinated and infected individuals and elucidate the mechanism of action of broadly neutralizing antibodies and dissect antibodies at the epito...
Main Authors: | Chen, X, Mohapatra, A, Nguyen, HTV, Schimanski, L, Kit Tan, T, Rijal, P, Chen, C, Cheng, S, Lee, W, Chou, Y, Townsend, AR, Ma, C, Huang, KA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2024
|
Similar Items
-
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
by: Shixia Wang, et al.
Published: (2022-12-01) -
Optimizing immunization protocols to elicit broadly neutralizing antibodies
by: Sprenger, Kayla G, et al.
Published: (2021) -
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
by: Delphine Planas, et al.
Published: (2024-03-01) -
Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
by: Mengxiao Luo, et al.
Published: (2023-12-01) -
Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose
by: Yuemiao Zhang, et al.
Published: (2023-02-01)